alexa
Reach Us +44-1202-068036
Metabolomics Fingerprinting In Clinical Study Of Mutiple Sclerosis Disease | 8064
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Metabolomics fingerprinting in clinical study of mutiple sclerosis disease

International Conference and Exhibition on Metabolomics & Systems Biology

Agnieska Smolinska

ScientificTracks Abstracts: J Comput Sci Syst Biol

DOI: 10.4172/0974-7230.S1.02

Abstract
The composition of biofluids carries invaluable information about the biochemical status of a living organism. Cerebrospinal Fluid (CSF) is the biofluid, which is in closest interaction with the Central Nervous System (CNS). It is therefore the biofluid that best mirrors the biochemical status and processes in brain and CNS. The chemical composition of CSF may thus provide insights about metabolic pathways in the CNS. The comprehensive analysis of CSF may define the fingerprint of neurological diseases such as the Multiple Sclerosis (MScl). Our objective is to detect molecular biomarkers for MScl in CSF. For this we used 1 H Nuclear Magnetic Resonance ( 1 H -NMR) spectroscopy and Gas Chromatography coupled with Mass Spectrometry (GC-MS) in combination with chemometric analysis. The research results we will present are obtained from a clinical study on MScl. We examined the human CSF metabolomics profile of MScl group. It was then compared to group representing the early stage of MScl, i.e. clinically isolated syndrome of demyelination (CIS). This human dataset is very complex, because the biological variations and environmental variations are comparable in size or larger than the variance of interest. The challenge is then to still extract the relevant variances, which requires special, more sophisticated approaches. For this purpose we have applied a kernel-PLS-DA for fused NMR and GC-MS datasets in kernel space. In addition we implemented variable selection procedure which is based on SVM Recursive Feature Elimination for nonlinear kernel function. Using this approach we obtained discrimination between MScl group and CIS group with high prediction accuracy for class memberships. Variables importance in kernel space was achieved by applying the pseudo-samples concept, recently introduced in our group.
Biography
Agnieszka Smolinska completed her Msc in Chemistry in Poland (Silesian University in Katowice). Currently she is a PhD student in The Netherlands (Radboud University in Nijmegen). She is investigating metabolic profiles of autoimmune disease, especially Multiple Sclerosis.
Leave Your Message 24x7
Top